Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes

BACKGROUND: Neoadjuvant chemotherapy (NCT) is considered more effective in downstaging hormone receptor-positive (HR+) breast cancer than neoadjuvant endocrine therapy (NET), particularly in node-positive disease. This study compared breast and axillary response and survival after NCT and NET in HR+...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Lifen, Sugumar, Kavin, Keller, Eleanor, Li, Pamela, Rock, Lisa, Simpson, Ashley, Freyvogel, Mary, Montero, Alberto J., Shenk, Robert, Miller, Megan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330206/
https://www.ncbi.nlm.nih.gov/pubmed/34342757
http://dx.doi.org/10.1245/s10434-021-10459-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330206/
https://www.ncbi.nlm.nih.gov/pubmed/34342757
http://dx.doi.org/10.1245/s10434-021-10459-3

Ejemplares similares